DEA

RSS Feed for this category

Chronicle AM: CA&MA Polls, Kratom Proponents Mobilize, Canada OKs Prescription Heroin; More... (9/14/16)

The polling is looking good in Massachusetts and better in California, there will be no initiative for Michigan this year, kratom proponents fight a proposed DEA ban, Canada gives the go-ahead for expanded heroin prescribing, and more.

The Canadian government has cleared the way for limited heroin prescribing for hard-core users. (Creative Commons)
Marijuana Policy

Marijuana Could Be a $50 Billion a Year Industry Within a Decade. A new report from financial analysts Cowen & Company says the legal weed industry could grow to a $50 billion a year business by 2026. The report notes that legalizing pot in California alone could triple the size of the industry, currently around $6 billion a year.

California: LA Times Poll Has Prop 64 at 58%. The Prop 64 legalization initiative is supported by 58% of voters, according to a new USC Dornsife/Los Angeles Times poll. Only 34% said they would vote against the measure, with 8% undecided. "It's very clear that Californians' attitudes have changed dramatically on this issue over the last several years," said Dan Schnur, director of the poll and of the Jesse M. Unruh Institute of Politics at USC. "The opposition is going to have to identify a fairly sizable source of campaign funding if this initiative is to be close," he added.

California: Eyewitness News/Southern California Newsgroup Poll Has Prop 64 at 52%. The Prop 64 legalization initiative has 52% in a new poll from Eyewitness News/Southern California Newsgroup. Some 40% said they would vote no, with 8% undecided.

Massachusetts Poll Has Legalization Initiative Up By Five Points. A new poll from WBUR TV has support for the Question 4 legalization initiative at 50%, with 45% opposed. "There's some big demographic splits, particularly along age lines," pollster Steve Koczela said. "Younger people are very much in favor of legalization, and it declines steadily as you move up the age brackets to where you get to voters who are 60-plus, and they're opposed to it by a 17-point margin."

Federal Judge Puts Final Nail in Coffin of Michigan Legalization Initiative. A federal court judge rejected a last chance effort by MI Legalize to get its legalization initiative on the November ballot. Judge Linda Parker Tuesday denied a motion from the group to stop the printing of election ballots, saying there was not enough time to stop the election process. MI Legalize gathered enough signatures to qualify for the ballot, but some of them came outside a 180-day mandated by state law. MI Legalize challenged rulings by state officials that knocked those signatures off the tally, but lost in the state courts -- and now, in federal court.

Kratom

Kratom Supporters Fight Proposed DEA Ban. Proponents of the Southeast Asian plant with mild opium-like qualities have mobilized to block the DEA proposed emergency move to place the substance on Schedule I of the Controlled Substances Act. Hundreds marched in front of the White House Tuesday and more than 120,000 have signed a Change.org petition opposing the ban, meaning the White House will have to publicly address the issue.

International

Canada Has Approved Prescription Heroin. The Canadian government last week quietly approved new regulations that will allow doctors to prescribe diacetylmorphine (heroin) to long-term users who have not responded to more conventional approaches to weaning them from the drug. The Crosstown clinic in Vancouver is currently the only place in the country with a heroin maintenance program, but that should now not be the case for long.

British MPs Call for Medical Marijuana. The All Party Parliamentary Group on Drug Policy Reform has called for medical marijuana to be legalized in the United Kingdom. The call comes on the heels of a report by neurologist Dr. Mike Barnes urging that marijuana be moved from Schedule I to Schedule IV on the British drugs classification scheme. "Many hundreds of thousands of people in the UK are already taking cannabis for primarily medical reasons," said MP Caroline Lucas, who co-chairs the group. "It is totally unacceptable that they should face the added stress of having to break the law to access their medicine."

Chronicle AM: Denver Pot Social Use Init Makes Ballot, Kratom Fight Gathers Steam, More... (9/6/16)

Big city Texas prosecutors are increasingly dropping small-time pot cases, a Denver social use marijuana initiative qualifies for the ballot, kratom proponents move to block the DEA effort to place it on Schedule I, and more, including lots of international items.

Denver skyline (Creative Commons)
Marijuana Policy

Texas Big City Prosecutors Are Dismissing Small-Time Marijuana Cases. Prosecutors in the state's five most populous counties -- Bexar (San Antonio), Dallas, Harris (Houston), Tarrant (Ft. Worth), and Travis (Austin) -- are increasingly dismissing small-time pot possession charges. In Ft. Worth, the number of cases dropped rose from 9% in 2011 to 25% last year. In Dallas, the number dropped rose from 18% to 41% in the same period. Travis County prosecutors Dan Hamre explained. "Jurors would look at us like we are crazy," he said. "'You are spending your time, our time and the court's time on a small amount of personal marijuana?'"

Washington State Campaign to End Marijuana Possession Felonies Underway. Under marijuana legalization via I-502, the stat legalized the possession of up to 28 grams of pot, but possession of 40 grams or more remains a felony. A Change.org petition calling on state lawmakers to fix the law is now underway. It has more than a thousand signatures in ten days, but could always use more.

Denver Marijuana Social Club Initiative Qualifies for Ballot. An initiative from the Denver Social Use Campaign has qualified for the November ballot. It would allow for the creation of "designated consumption areas" for marijuana use. Permits would be open to a broad range of businesses, and could cover a single event or be good for up to a year. Patrons would have to bring their own buds, though, since sales would not be allowed.

Medical Marijuana

Second Arkansas Lawsuit Challenges Medical Marijuana Initiative. A Little Rock attorney who is a member of NORML's National Legal Committee has filed a lawsuit seeking to knock the Arkansas Medical Cannabis Act off the November ballot. In the lawsuit, attorney Kara Benca asked the court to invalidate some 15,000 voter signatures, which would disqualify the initiative. A second initiative, the Arkansas Medical Marijuana Amendment, has also qualified for the ballot. If both pass, the won with the most votes wins.

Drug Policy

Petition Drive to Undo Making Kratom Schedule I is Underway. In response to the DEA's announcement it was moving to make kratom's active ingredients Schedule I, fans of the opioid substitute have begun a Change.org petition asking the White House to intervene. The White House must respond if the petition hits 100,000 signatures by month's end. So far, it has nearly 70,000. The American Kratom Association also says it is pondering a lawsuit to block the move.

International

Australia Will Legalize Medical Marijuana in November. The Therapeutic Goods Administration has made it official. The agency has now formally announced it will move medical marijuana from Schedule 9 (prohibited substances) to Schedule 8 (controlled drugs). The change will go into effect in November.

Bolivian Government Proposes Prison Time for Illegal Coca Cultivation. Vice Minister for Social Defense Felipe Caceres announced Friday that the government is proposing a bill that would make illegal coca production a crime punishable by up to three years in prison. Under current law, illegal cultivators face no prison time, only the destruction of their crops.

Colombia Attorney General Calls for Renewed Aerial Eradication of Coca Crops. Attorney General Nestor Humberto Martinez has released a report calling for a resumption of aerial spraying of coca groups with herbicides. The government ended that policy las year, citing health risks, as well as a desire to emphasize public health and human rights in its drug policies. But an expansion of coca production has the government signaling it may change its tune.

Denmark's Christiania Residents Tear Down Hash Stalls After Police Shot and Wounded. Christiania has long been the go-to place to score hash in Copenhagen, but after a known drug seller opened fire on police last week, wounding two, residents of the hippie enclave began tearing down dealers' stalls, saying they feared organized crime was moving in. "If they start building up the booths again tonight, then well, we're here tonight as well. The plan is to continue tearing them down until it works," Christiania resident Helene Schou said. "I'm not saying hash should disappear completely from Christiania, but we needed a kiosk and what we had was a supermarket."

Philippines Will Make Drug Tests Mandatory for College Students. In the latest move in President Rodrigo Duterte's murderous war on drugs, his administration has announced it will seek to make students entering college undergo drug tests beginning next year. More than 2,400 people accused of being drug users or sellers have been killed in Duterte's two months in office, and his administration has instituted broad drug testing of police and politicians, among others.

A Long Hot Summer of Drug War Deaths [FEATURE]

The killing of a young, black, unarmed Tampa man by a SWAT team that raided his home in an operation that turned up two grams of marijuana has sparked angry protests last week, including demonstrations last Thursday where people damaged vehicles, lit fires, and threw trash at police, leaving five people arrested and a community outraged.

Levonia Riggins. Unarmed, killed in his bedroom in a raid that netted two grams of weed. (family photo)
Levonia Riggins was shot and killed in his bedroom by Deputy Caleb Johnson of the Hillsborough County Sheriff's Office as the SWAT team executed a search warrant based on purchases of marijuana from Riggins by undercover officers earlier this summer. Police said they used the SWAT team because they had found guns in the house a year earlier.

When deputies arrived, they broke through a window and found Riggins in bed. "Mr. Riggins then jumped up and moved his hands toward his waistband," a police spokesman explained. Johnson then fired, killing Riggins in what police called "a split-second decision." The Hillsborough State Attorney's Office is now investigating the killing, as is a sheriff's internal team.

Riggins was only the last person to be killed in drug law enforcement operations this summer that left 10 other people dead in separate incidents, including a Tennessee police officer. According to the Drug War Chronicle, which has been tracking such deaths since 2011, the year's drug war death toll now stands at 33.

That's a rate of about one a week, a rate that has held constant throughout the five years the Chronicle has been counting. Also consistent is the ratio of civilians killed to police officers killed. It has been running at about 10:1 over the five-year period, and with three officers killed so far this year, that ratio is being maintained.

Here are the rest of the summer's drug war victims and the circumstances of their deaths:

On August 18, in Apache Junction, Arizona, a Maricopa County sheriff's SWAT Team member shot and killed Larry Eugene Kurtley, Jr., 53, as the SWAT team attempted to take him into custody on drugs, drug paraphernalia, and weapons charges. A woman who left the residence as police arrived told them he could be armed, and the SWAT team then began to negotiate his surrender, police said. But Kurtley refused to come out, so police fired tear gas into the home. When he emerged from the house, he was armed, police said, and one of the SWAT deputies opened fire, killing him. Kurtley had served multiple prison sentences dating back to the 1990s. The Pinal County Attorney's Office and the sheriff's office professional standards bureau are investigating.

On August 16, just outside Augusta, West Virginia, a sheriff's deputy shot and killed John O'Handley, 55, of Yellow Springs as he reportedly grabbed the deputy's gun while being transported to jail after being arrested on methamphetamine and other charges. Deputies had originally gone to O'Handley's residence in search of a stolen motorcycle, but discovered an active meth lab in the home, as well as homemade bombs and stolen property. O'Handley allegedly reached between the front seats of the police car and grabbed the arresting deputy's gun. "A struggle then ensued," and the deputy fired one shot, striking O'Handley in the head and killing him. The shooting is being investigated by the West Virginia State Police.

Tennessee Bureau of Investigation Special Agent De'Greaun Frazier. Killled during an undercover drug buy. (tn.gov/tbi)
On August 9, in Jackson, Tennessee, a Tennessee Bureau of Investigation agent was shot and killed while conducting an undercover drug buy. Special Agent De'Greaun Frazier, 35,was assisting Jackson Metro Narcotics and was in the front seat of a vehicle when the man he was supposed to buy drugs from instead tried to rob him, shooting him from the back seat. That man, Brendan Burns, has now been charged with murder in his death. Frazier had earlier served on a DEA task force while working at the Millington Police Department.

On August 9, in Los Angeles, LAPD officers in Boyle Heights shot and killed Jesse Romero, 14, as he fled from them while they investigated a report of possible "gang writings" and drug activity. According to the LAPD account, Romero and another youth split up and took off running when police arrived, and a witness saw Romero shoot a handgun toward pursuing officers. One officer returned fire, striking and killing Romero. But another witness said she saw Romero pull a gun from his basketball shorts as he ran, then toss it toward a fence. The gun fired when it fell to the ground after hitting the fence, startling Romero. "He didn't shoot," she said. Police recovered an old revolver, but it is unclear how near it was to Romero's body. The officers involved were wearing body cameras, but under LAPD policy that footage is only released to the officers involved before they make an initial statement -- not to the public. The ACLU of Southern California released a statement saying it was "particularly concerned" about Romero's death and criticizing LAPD's body camera policies.

On July 7, in Clovis, California, Clovis Police serving an arrest warrant on narcotics and related charges shot and killed Adam Smith, 33, as he attempted to flee in his vehicle. Police and his girlfriend's family lured him to the family residence, but he and his girlfriend tried to escape, jumping in his van in an alley. According to police, when they confronted the pair in the alley, the girlfriend jumped out of the van, Smith slammed it into reverse, nearly hitting her, then accelerated his vehicle toward the officers. Two of the three offices opened fire, fatally wounding Smith. He was not named in initial reports, but was later identified. In another report, an acquaintance said Smith was on heroin and had repeatedly said they he would die in a "suicide by cop," especially when he was on heroin.

Street meorial for 14-year-old Jesse Romero. (scpr.org)
On June 30, in Douglas, Wyoming, a US marshal shot and killed Jasen Scott Ramirez, 44, in the parking lot of a Catholic Church as he was leaving his father's funeral. The federal agents were seeking Ramirez to serve an arrest warrant on methamphetamine and weapons charges. Local police called to the scene after the shooting discovered 3.5 ounces of meth and two pistols in the vehicle he was driving, but it's unclear to whom the car, the guns, or the drugs belonged. It's also unclear whether Ramirez was brandishing or reaching for a weapon when he was shot and killed. The US Marshals Service has issued only a one-paragraph statement, short on details, including the name of the marshal who pulled the trigger. The agency said it would not be saying more until all investigations into the incident are concluded, including one by the Wyoming Division of Criminal Investigation. After the killing, an unconfirmed death threat was made against law enforcement, prompting authorities to temporarily lock down the county courthouse, city hall, and the hospital where Ramirez died.

On June 16, in Westminster, Colorado, a Westminster police officer shot and killed Nicholas Damon, 30, after Damon allegedly dragged the officer and ran over him with his car. Police were attempting to arrest Damon on outstanding drug and assault warrants when he hopped into his car and attempted to flee the scene. The officer involved was briefly hospitalized with "non-life threatening injuries." The killing is being reviewed by an Adams County special investigatory team.

On June 14, in Chula Vista, California, an undercover ICE agent shot and killed Fernando Geovanni Llanez, 22, as agents met with a half-dozen suspected marijuana traffickers in an apparent buy-bust deal at an Eastlake-area strip mall. The agent was part of the Homeland Security Investigations Operation Alliance drug task force, and the agency said Llanez attacked him in what could have been a robbery attempt. The agent fired several times, fatally wounding Llanez. His five companions fled, but were all chased down and arrested on charges of possession of marijuana for sale, conspiracy, and suspicion of robbery. Chula Vista police declined to confirm that it was an undercover operation and would not say if any cash or drugs were seized. There was no mention of any weapon.

On June 8, in Kansas City, Missouri, members of a DEA task force executing a search warrant shot and killed Carlos Garcia, 43, after he fired at officers from inside the house and then refused to exit, leading to an hours-long standoff. Finally, after police shot tear gas into the house, Garcia ran out the back door of the residence aiming his rifle at officers, police said. Task force members then opened fire on Garcia, killing him in the back yard.

On June 7, in Turlock, California, two Modesto police officers who were members of the Stanislaus County Drug Enforcement Agency "involved in a narcotics investigation" shot and killed Omar Villagomez after the vehicle he was driving collided with unmarked police vehicles as they attempted to arrest him. The passenger in the vehicle was not shot, but was injured by debris from the collision. He was charged with suspicion of meth possession with intent to sell, transportation of meth, possession of a controlled substance while armed, and possession of a loaded and concealed firearm.

DEA Places Kratom on Schedule I, the Same Status as Heroin

The DEA announced Tuesday that it plans to crack down on kratom, a Southeast Asian plant that has gained increasing popularity among chronic pain sufferers and people wishing to wean themselves from opioids.

Kratom. Only on the shelves for another 30 days. (Creative Commons)
The drug agency said it was using its emergency powers to place two psychoactive substances in the plant -- mitragynine and 7-hydroxymitragynine -- on Schedule I of the Controlled Substances Act, the same schedule as heroin. The move will take effect by the end of September and will be in effect for up to three years.

"Kratom has a high potential for abuse, has no currently accepted medical use in treatment in the United States, and has a lack of accepted safety for use under medical supervision," the defining characteristics of a Schedule I drug, the DEA said.

Kratom was traditionally used in Thailand and Malaysia to help endure physical labor, relieve pain, and stop diarrhea. It was also good for relieving the symptoms of opium withdrawal.

That's because it acts like an opiate. Its active ingredients activate the same opioid receptors heroin and prescription pain pills do. And it behaves like an opiate -- with a couple of exceptions, one interesting and one quite important.

Like other opiates, it relieves pain, slows bowel activity, produces euphoric feelings, and creates physical addiction and a withdrawal syndrome. But unlike other opiates, it causes a pleasant, caffeine-type buzz in small doses and, more significantly, it is apparently very difficult -- if not impossible -- to overdose on it. The few deaths where kratom is implicated include poly-drug use, or as in a case reported by the New York Times, suicide by a young kratom user who was also being treated for depression.

And it has caught on here in the United States, especially among pain patients and people seeking to transition from opioid addiction, so much so that the DEA said it needed to act "in order to avoid an imminent threat to public safety." Calls to poison control centers about kratom jumped from a mere two between 2000 and 2005 to 660 between 2010 and 2015. DEA reported 15 "kratom-related" deaths between 2014 and now.

But that's out of millions of doses. According to DEA's own data, at least 130,000 pounds of kratom was seized by law enforcement in the last two years, and the FDA has ordered another 140,000 pounds of the stuff held pending an admissibility decision. That's enough for some 12 million doses, and that's just what they seized.

The DEA decision will doubtless lead to the removal of falsely-labeled and tainted products claiming to be kratom, but it's also likely to drive thousands of people with chronic pain and opioid problems back to the substances they were trying to avoid. And when it comes to lethality, kratom is opium's mild-mannered little sister. While the DEA cites 15 deaths linked to kratom since 2014, there were more than 29,000 fatal opioid overdoses in 2014 alone.

Washington, DC
United States

Chronicle AM: DEA to Make Kratom Schedule I, Thailand to Downschedule Meth, More... (8/30/16)

The DEA announces it will make the active ingredients in kratom Schedule I substances, marijuana legalization initiatives in Arizona and Michigan go to court, the Thai government is moving to reform the way it deals with meth, and more.

Kratom is headed for Schedule I (Creative Commons/Wikipedia)
Marijuana Policy

Arizona Legalization Campaign Sues Over Ballot Description. The Campaign to Regulate Marijuana Like Alcohol filed a lawsuit Monday asking the state Supreme Court to fix what is says is inaccurate language in the ballot description of Prop 205 that will be presented to voters. The description written by Secretary of State Michele Reagan left out information that the campaign says is important, such as noting that a new 15% marijuana tax would go mainly to schools. The Supreme Court is also hearing a challenge from opponents of Prop 205. It needs to finalize the ballot language today.

Michigan Legalization Campaign Asks State Supreme Court to Put Initiative on Ballot. In a last ditch bid to get its legalization initiative on the November ballot, MI Legalize has filed a motion with the Supreme Court asking it to overturn a lower court's ruling that the state had no obligation to include signatures gathered outside a 180-day window. MI Legalize gathered more than enough signatures to qualify for the ballot, but some of them were deemed too old to be counted.

Medical Marijuana

Arkansas Democratic Party Endorses Medical Marijuana. With two competing medical marijuana initiatives on the ballot, the state Democratic Party has approved a platform plank endorsing medical marijuana. The plank calls for "the development of a responsible medical marijuana program that will receive patients in need of such relief the freedom to access this remedy."

Drug Policy

DEA to Place Kratom on Schedule I. The DEA announced Wednesday that it is moving to place the active materials in the kratom plant on Schedule I of the Controlled Substances Act. That schedule is reserved for drugs that have no medical use and a high potential for abuse. The scheduled substances are mitragynine and 7-hydroxymitragynine. Kratom is a tropical tree indigenous to Southeast Asia. It produces opioid-like effects and has been marketed as a legal alternative to controlled substances. Not anymore, though.

International

Hundreds of Argentine Judges, Lawyers Call for End to Drug War. Some 500 magistrates, lawyers, and other legal figures used the 30th anniversary of key Supreme Court decision to call for an end to the war on drugs. In 1986, in the "Bazterrica" ruling, the nation's high court ruled it unconstitutional to prosecute people for simple drug possession. Yet Argentine law still allows such prosecutions. The legal figures are demanding that the law be changed to be in compliance with the Bazterrica ruling.

Thailand Takes Another Step Toward Moving Meth off Dangerous Drugs List. The Justice Ministry is set to remove methamphetamine from its list of dangerous drugs, which would allow health authorities to use it for medical reasons. The move is part of a larger shift in how the country deals with drug use, and is part of a bill that will emphasize treatment for drug users, including substituting prescription stimulants such as Modafinil for meth. The government has given no time line for when the bill will move.

Chronicle AM: Clinton Renews Rescheduling Call, Kerry Gets MX Human Rights Letter, More... (8/12/16)

The DEA's refusal to reschedule marijuana yesterday elicits reactions from Hillary Clinton and DC activists, a California bill to tax medical marijuana farmers dies in committee, Secretary of State Kerry gets a letter from Congress urging him to prioritize human rights when it comes to financing Mexico's drug war, and more.

DC activists are set to give the White House an earful after the DEA refused to reschedule marijuana.
Marijuana Policy

In Wake of DEA Decision, Hillary Clinton Reiterates Call for Rescheduling Marijuana. Democratic presidential candidate Hillary Clinton will move to reclassify marijuana as a Schedule II substance, her campaign said in a statement after the DEA rejected reclassification Thursday. "As president, Hillary will build on the important steps announced today by rescheduling marijuana from a Schedule I to a Schedule II substance. She will also ensure Colorado, and other states that have enacted marijuana laws, can continue to serve as laboratories of democracy," senior Clinton advisor Maya Harris said.

In Wake of DEA Decision, Emergency Demonstration at the White House Tonight. Washington, DC, DCMJ legalization activists are gathering in front of the White House tonight at 8:20 PM to protest the DEA's refusal to move marijuana from Schedule I, the same schedule as heroin. "Here we are, 43 years and millions of marijuana arrests later, and we being told that cannabis is still as dangerous as heroin. WHAT THE HELL?!?!" organizers wrote on Facebook. "The Obama Administration's DEA thinks Americans should go to jail for a non-toxic plant. WE THINK OTHERWISE!"

Medical Marijuana

California Medical Marijuana Tax Bill Dies in Committee. A bill that would have imposed a tax on commercial medical marijuana growers has been killed in the Senate Appropriations Committee. Assembly Bill 2243 would have imposed a tax of up to $9.25 per ounce of marijuana buds, $2.75 for pot leaves, and $1.25 for immature pot plants. The panel killed the bill after patient advocates said it would impose a burden on patients.

International

Canadian Medical Marijuana Patients Will Be Able to Grow Their Own. Health Canada said Thursday that medical marijuana patients will be able to grow limited amounts for themselves or have a caregiver do so. The move comes as the government attempts to comply with a federal court ruling that struck down the previous Conservative government's ban on patients growing their own. Patients would also still have the option of buying from one of 34 producers licensed by the federal government.

Congresspersons Sign Letter to Secretary of State Kerry Urging That US Prioritize Human Rights in Mexico. Some 68 members of Congress have signed onto a letter urging Kerry to make human rights a priority in US relations with Mexico. The letter expresses concern over the "27,000 unresolved cases of people who have disappeared in Mexico since 2007, and the slow pace of reforms in the military, law enforcement and justice sectors," as well as the persistent use of torture in criminal investigations. It calls for US support for the ongoing investigation and search for the 43 disappeared students from the Ayotzinapa rural teachers' college. And it reiterates the need for accountability and justice in the cases of grave abuses committed by Mexican security forces in Oaxaca and Tlatlaya. The letter comes as the State Department is reviewing the Mexican government's compliance with human rights conditions attached to US anti-drug funding.

(This article was prepared by StoptheDrugWar.org"s lobbying arm, the Drug Reform Coordination Network, which also pays the cost of maintaining this web site. DRCNet Foundation takes no positions on candidates for public office, in compliance with section 501(c)(3) of the Internal Revenue Code, and does not pay for reporting that could be interpreted or misinterpreted as doing so.)

DEA's Marijuana Rescheduling Rejection Is Disappointing, But Doesn't Have Much Impact [FEATURE]

This article was produced in collaboration with AlterNet and an earlier version appeared here.

The DEA's decision Thursday not to move marijuana from Schedule I of the Controlled Substances Act (CSA) ended months of speculation about whether the agency would finally act in accordance with an ever-increasing mountain of evidence of marijuana's medicinal utility and either schedule it less restrictively or deschedule it altogether.

Supporters of more enlightened marijuana policies were disappointed, but not surprised. After all, the DEA has a long history of rejecting and impeding science when it comes to marijuana. But even had DEA acted (it did ease the University of Mississippi's monopoly on growing marijuana for research purposes), the most likely move would have been grudgingly incremental, shifting marijuana from a schedule where it is grouped with heroin down to Schedule II, where it would be grouped with cocaine and methamphetamines, and still not prescribable absent FDA approval.

Or the agency could have taken some other largely unpalatable stance, such as making cannibidiol a Schedule III substance (like synthetic Marinol) while leaving the whole plant Schedule I. In any case, any move short of descheduling it entirely and treating it like alcohol and tobacco, would have left marijuana medicalized, but not normalized.

The article below was written days before the DEA's decision, but we think the discussion remains germane for understanding the issues around rescheduling and why most reformers are disappointed, but not devastated by the agency's stubborn refusal to budge.

While the DEA may move to reschedule marijuana to a lesser schedule, keeping it within the purview of the Controlled Substances Act means that it would still be illegal, even for medical use in the absence of FDA approval. Even with FDA approval, a years-long process, it would still require a prescription to obtain, which would do nothing to address legal adult marijuana sales, production, or possession in the states. Removing it from the CSA, or descheduling, is what consumers and the industry are calling for, but that is the unlikeliest outcome, even though that's how we deal with the two most commonly used recreational drugs in the United States, alcohol and tobacco.

Schedule I is reserved for substances that have "no currently accepted medical use and a high potential for abuse," the DEA notes. "Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence." Those drugs include heroin, Ecstasy, LSD, peyote…and marijuana.

For more than 40 years, the DEA has blocked efforts to have marijuana placed in a more appropriate schedule, one that reflects the plant's medicinal uses as well as its relative harmlessness compared to other scheduled substances. But that stance has grown increasingly untenable in the face of state-level medical marijuana programs and in the face of an ever-larger mountain of research that fails to find significant serious health consequences from marijuana use.

Now, the DEA is considering a decision on the most recent rescheduling petition. Earlier this year, the agency told lawmakers it "hopes to release its determination in the first half of 2016," but that clearly didn't happen. Late in June, DEA spokesman Russ Baer said the agency is "in the final stages" of making its determination. And just last week, Baer said, "We're closer than we ever were. It's a very deliberative process."

If the DEA decides not to keep marijuana in Schedule I, the most obvious incremental move would be for it to bump it down one step to Schedule II, placing pot in the same category as morphine, cocaine, and methamphetamine. That could pave the way for eventually allowing doctors to prescribe it, and would remove some roadblocks to further research. It might open the way for broader changes in financial and business regulations, although a shift to Schedule III or greater would be needed to address the debilitating 280E tax provision, which prevents cannabusinesses from deducting ordinary expenses like rent or payroll.

The DEA still doesn't see the "medical" in "medical marijuana." (Wikimedia/Creative Commons)
But Schedule II, or any of the lesser schedules, would require that marijuana be approved by Food and Drug Administration (FDA), a lengthy and expensive process that could bankrupt businesses attempting to overcome those regulatory hurdles. And until that happens, there is no approved marijuana for doctors to prescribe. It's also unclear whether the FDA would ever approve smoked marijuana.

Members of the marijuana industry, medical marijuana advocates, and marijuana consumer advocacy groups alike expressed skepticism about the DEA's willingness or ability to respond to the scientific evidence, uncertainty about what the agency was likely to do, and a demonstrated a pronounced -- if not unanimous -- preference not for rescheduling, but for descheduling.

Matthew Huron is a founder and former board member of the National Cannabis Industry Association and founder and current CEO of Good Chemistry Colorado, a vertically integrated cannabis company, as well as the co-founder of the Wellspring Collective, which caters to seniors with health challenges. Huron isn't exactly enthused by the prospect of Schedule II.

"Just to move it to Schedule II is more complicated than we're reading about," he said. "It might just be the molecule that gets rescheduled -- not cannabis. I don't think moving it to Schedule II would really have much effect on the states. It wouldn't hurt, but it wouldn't really help. Most of us in the industry would like to see it descheduled."

The medical marijuana advocacy group Americans for Safe Access (ASA) is pushing for Schedule II, but it's not relying on the DEA to make it happen.

"We don't have a crystal ball, and we don't know what the DEA will do, but based on past history, we don't have high hopes they will reschedule," said ASA spokesperson Melissa Wilcox. "It's possible they will de- or reschedule CBD and leave whole plant cannabis at Schedule I. Who knows? The DEA tends to ignore the science."

Schedule II "would remove barriers to scientists wishing to do research, so we know best how to use cannabis -- targeting, dosing, all the questions we haven't been able to study because it is such a pain to get research done now," said Wilcox.

But with little faith in the DEA, ASA is instead pushing for a legislative solution, the Compassionate Access, Research Expansion, and Respect States' Rights (CARERS) Act, also known as S. 683, which is currently bottled up in the Senate Judiciary Committee, chaired by octogenarian prohibitionist Sen. Chuck Grassley (R-IA).

The CARERS Act would move marijuana to Schedule II, as well as deschedule CBD, open up access to marijuana business banking, and end the NIDA monopoly on growing marijuana for research, among other provisions.

"We're pretty sure this could pass, but Grassley is the gatekeeper, and we're pushing hard to get him to schedule a vote," said Wilcox.

"Moving marijuana to Schedule II is not a solution," said Mason Tvert, communications director for the Marijuana Policy Project, which has played -- and continues to play -- a major role in advancing both medical marijuana and legalization at the state level. "It would certainly remove barriers to research, but it would still treat marijuana as if it were as harmful as cocaine and other illegal substances, when it is objectively less harmful than alcohol. We fully support removing marijuana from the schedules and treating it like alcohol," Tvert emphasized.

"We think marijuana should be removed entirely from the Controlled Substances Act," said Dale Gieringer, long-time head of California NORML, representing consumers and small growers in the nation's most populous state. "As a fallback position, we've been litigating since 1972 to get it rescheduled to Schedule II. If they do that, that would be good -- they'd only be 45 years overdue," he noted.

"From the standpoint of states that have state-legal suppliers, Schedule II doesn't accomplish a whole lot," Gieringer said. "Those state-legal suppliers wouldn't become federally legal; they'd have to first obtain FDA approval. Until that happens, everybody is an illegal producer of a scheduled drug under federal law," he said.

"Schedule II would allow doctors to write prescriptions -- but nobody could fill them," Gieringer noted. "There are international prescriptions and international suppliers, though. But the main impact would be doctors would feel better and cops couldn't argue that marijuana isn't a medicine. If they're trying to create a niche for existing legal medical marijuana state, putting it in Schedule II is like creating a square hole for a round peg."

Marijuana patients, consumers, and the industry are all waiting for the DEA to act, but aren't really holding out much hope it will do the right thing. And even the half-steps it might take, such as moving it to Schedule II or separating out CBDs for lower scheduling, aren't going to substantially alter marijuana's legal status or resolve the conflicts between state-level legality and federal marijuana prohibition. When it comes to rescheduling marijuana, there's just not that much there there.

Medical Marijuana Update

The DEA again rejects marijuana rescheduling, a North Dakota initiative makes the ballot, a South Dakota one doesn't, a Missouri one hangs on by a thread, and more.

National

On Thursday, DEA again refused to reschedule marijuana. The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility. Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result. The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

Missouri

On Monday, a medical marijuana initiative campaign vowed to go to court to try to overturn invalidated signatures. New Approach Missouri announced that it will go to court this month to overturn invalidated signatures so that its medical marijuana initiative can appear on the November ballot. The campaign has enough valid signatures to qualify in every congressional district except the state's second, where local election officials invalidated more than 10,000 signatures, leaving the campaign roughly 2,200 short of the 32,337 required in that district.

Ohio

On Tuesday, Ohio took the first step toward getting medical marijuana up and running. The state Medical Marijuana Control Program has unveiled a website with the first information on how it plans to implement the state's new medical marijuana law. Medical marijuana will not be available before September 2018, as the state works to develop rules and regulations.

North Dakota

On Tuesday, a medical marijuana initiative qualified for the November ballot. The secretary of state's office has confirmed that Compassionate Care Act initiative has submitted enough valid signatures to qualify for the November ballot. The initiative would allow patients suffering from a list of specified medical conditions to possess up to three ounces of marijuana and grow their own if they are more than 40 miles away from a licensed dispensary. Dispensaries would be nonprofits.

South Dakota

On Tuesday, a state court judge rejected a medical marijuana initiative campaign's appeal. The state will not be voting on the issue this November after a state court judge denied a request from the campaign to overturn Secretary of State Shantel Krebs' finding that the group did not hand in enough valid voter signatures to qualify for the ballot. South Dakota has twice previously rejected medical marijuana at the polls -- the only state to do so.

[For extensive information about the medical marijuana debate, presented in a neutral format, visit MedicalMarijuana.ProCon.org.]

Chronicle AM: DEA Rejects MJ Rescheduling, AZ Legalization Init Makes Ballot, More... (8/11/16)

The DEA is up to the same old same old, Arizona joins the list of states voting on marijuana legalization this fall, heroin overdoses jump in recent years in New York, and more.

Marijuana Policy

DEA Again Refuses to Reschedule Marijuana. The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility. Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result. The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

Arizona Legalization Initiative Qualifies for November Ballot. It's official: State officials have confirmed that the initiative from the Campaign to Regulate Marijuana Like Alcohol has gathered enough valid voter signatures to qualify for the November ballot. The initiative will appear on the ballot as Proposition 205.

Heroin and Prescription Opioids

Fatal Overdoses Have Jumped in New York City in Recent Years. Fatal drug overdoses have jumped 66% in the city between 2010 and 2015, the city Department of Health and Mental Hygiene Reported Tuesday. Last year, 937 New Yorkers died of overdoses, compared to 541 in 2010. Heroin was involved in 59% of the deaths.

International

Vietnam Sentences Nine to Death for Smuggling Heroin to China. A court in Lang Son has handed out death sentences to nine men for smuggling about 500 pounds of heroin to China. Two others were sentenced to life in prison. Under Vietnamese law, possession or sale of more than 100 grams of heroin is punishable by death.

DEA Once Again Refuses to Reschedule Marijuana, But Does Offer One Sop [FEATURE]

The DEA today again refused to reschedule marijuana, arguing that its therapeutic value has not been scientifically proven. The move rejecting a rescheduling petition from two governors comes despite medical marijuana being legal in half the states and in the face of an ever-increasing mountain of evidence of marijuana's medicinal utility.

"DEA has denied two petitions to reschedule marijuana under the Controlled Substances Act (CSA)," the agency said in a press release. "In response to the petitions, DEA requested a scientific and medical evaluation and scheduling recommendation from the Department of Health and Human Services (HHS), which was conducted by the U.S. Food and Drug Administration (FDA) in consultation with the National Institute on Drug Abuse (NIDA). Based on the legal standards in the CSA, marijuana remains a schedule I controlled substance because it does not meet the criteria for currently accepted medical use in treatment in the United States, there is a lack of accepted safety for its use under medical supervision, and it has a high potential for abuse."

Today's action marks at least the fourth time the DEA has rejected petitions seeking to reschedule marijuana. The effort to get the DEA to move marijuana off the same schedule as heroin has been going on since 1972, and once again has garnered the same result.

The move comes despite the expansion of state medical marijuana laws at least three more states will vote on it this year -- and a growing clamor for change, including from members of Congress. Just yesterday, the National Conference of State Legislatures adopted a resolution calling on the federal government to move marijuana off Schedule I.

The agency did announce one policy change that could make it easier to conduct marijuana research. It said it would end the University of Mississippi's monopoly on the production of marijuana for research purposes by granting growing licenses to a limited number of other universities.

But that was not nearly enough for marijuana reform advocates, who scorched the agency for its continuing refusal to move the drug off of Schedule I, if not outside the purview of the Controlled Substances Act altogether.

"This decision is further evidence that the DEA doesn't get it. Keeping marijuana at Schedule I continues an outdated, failed approach -- leaving patients and marijuana businesses trapped between state and federal laws," said Rep. Earl Blumenauer (D-OR).

The DEA again refuses to acknowledge marijuana's medicinal utility. (Creative Commons/Wikipedia)
"The DEA's refusal to remove marijuana from Schedule I is, quite frankly, mind-boggling. It is intellectually dishonest and completely indefensible. Not everyone agrees marijuana should be legal, but few will deny that it is less harmful than alcohol and many prescription drugs. It is less toxic, less addictive, and less damaging to the body," said Mason Tvert, communications director for the Marijuana Policy Project.

"We are pleased the DEA is finally going to end NIDA's monopoly on the cultivation of marijuana for research purposes. For decades it has been preventing researchers from exploring the medical benefits of marijuana. It has also stood in the way of any scientific inquiries that might contradict the DEA's exaggerated claims about the potential harms of marijuana or raise questions about its classification under Schedule I," Tvert continued.

"The DEA's announcement is a little sweet but mostly bitter. Praising them for it would be like rewarding a student who failed an exam and agreed to cheat less on the next one. Removing barriers to research is a step forward, but the decision does not go nearly far enough. Marijuana should be completely removed from the CSA drug schedules and regulated similarly to alcohol," he concluded.

"For far too long, federal regulations have made clinical investigations involving cannabis needlessly onerous and have placed unnecessary and arbitrary restrictions on marijuana that do not exist for other controlled substances, including some other schedule I controlled substances," said Paul Armentano, deputy director of NORML.

"While this announcement is a significant step toward better facilitating and expanding clinical investigations into cannabis' therapeutic efficacy, ample scientific evidence already exists to remove cannabis from its schedule I classification and to acknowledge its relative safety compared to other scheduled substances, like opioids, and unscheduled substances, such as alcohol," he continued. "Ultimately, the federal government ought to remove cannabis from the Controlled Substances Act altogether in a manner similar to alcohol and tobacco, thus providing states the power to establish their own marijuana regulatory policies free from federal intrusion.

It is time for Congress to step up, Armentano said.

The DEA's approach. (DEA)
"Since the DEA has failed to take such action, then it is incumbent that members of Congress act swiftly to amend cannabis' criminal status in a way that comports with both public and scientific opinion. Failure to do so continues the federal government's 'Flat Earth' position; it willfully ignores the well-established therapeutic properties associated with the plant and it ignores the laws in 26 states recognizing marijuana's therapeutic efficacy," he said.

He wasn't the only one.

"It's really sad that DEA has chosen to continue decades of ignoring the voices of patients who benefit from medical marijuana," said Tom Angell, chairman of Marijuana Majority. "President Obama always said he would let science -- and not ideology -- dictate policy, but in this case his administration is upholding a failed drug war approach instead of looking at real, existing evidence that marijuana has medical value. This unfortunate decision only further highlights the need for Congress to pass legislation curtailing the ability of DEA and other federal agencies to interfere with the effective implementation of state marijuana laws. A clear and growing majority of American voters support legalizing marijuana outright and the very least our representatives should do is let states implement their own policies, unencumbered by an outdated 'Reefer Madness' mentality that some in law enforcement still choose to cling to."

Given that the DEA and the executive branch have proven -- once again! -- unwilling to remove the ideological blinders from their eyes, it is now indeed up to Congress. Perhaps after this coming election cycle, in which we are likely to see more states vote to approve medical marijuana and even more vote to just legalize it, Congress will see the writing on the wall.

Washington, DC
United States

Drug War Issues

Criminal JusticeAsset Forfeiture, Collateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Court Rulings, Drug Courts, Due Process, Felony Disenfranchisement, Incarceration, Policing (2011 Drug War Killings, 2012 Drug War Killings, 2013 Drug War Killings, 2014 Drug War Killings, 2015 Drug War Killings, 2016 Drug War Killings, 2017 Drug War Killings, Arrests, Eradication, Informants, Interdiction, Lowest Priority Policies, Police Corruption, Police Raids, Profiling, Search and Seizure, SWAT/Paramilitarization, Task Forces, Undercover Work), Probation or Parole, Prosecution, Reentry/Rehabilitation, Sentencing (Alternatives to Incarceration, Clemency and Pardon, Crack/Powder Cocaine Disparity, Death Penalty, Decriminalization, Defelonization, Drug Free Zones, Mandatory Minimums, Rockefeller Drug Laws, Sentencing Guidelines)CultureArt, Celebrities, Counter-Culture, Music, Poetry/Literature, Television, TheaterDrug UseParaphernalia, ViolenceIntersecting IssuesCollateral Sanctions (College Aid, Drug Taxes, Housing, Welfare), Violence, Border, Budgets/Taxes/Economics, Business, Civil Rights, Driving, Economics, Education (College Aid), Employment, Environment, Families, Free Speech, Gun Policy, Human Rights, Immigration, Militarization, Money Laundering, Pregnancy, Privacy (Search and Seizure, Drug Testing), Race, Religion, Science, Sports, Women's IssuesMarijuana PolicyGateway Theory, Hemp, Marijuana -- Personal Use, Marijuana Industry, Medical MarijuanaMedicineMedical Marijuana, Science of Drugs, Under-treatment of PainPublic HealthAddiction, Addiction Treatment (Science of Drugs), Drug Education, Drug Prevention, Drug-Related AIDS/HIV or Hepatitis C, Harm Reduction (Methadone & Other Opiate Maintenance, Needle Exchange, Overdose Prevention, Pill Testing, Safe Injection Sites)Source and Transit CountriesAndean Drug War, Coca, Hashish, Mexican Drug War, Opium ProductionSpecific DrugsAlcohol, Ayahuasca, Cocaine (Crack Cocaine), Ecstasy, Heroin, Ibogaine, ketamine, Khat, Kratom, Marijuana (Gateway Theory, Marijuana -- Personal Use, Medical Marijuana, Hashish), Methamphetamine, New Synthetic Drugs (Synthetic Cannabinoids, Synthetic Stimulants), Nicotine, Prescription Opiates (Fentanyl, Oxycontin), Psychedelics (LSD, Mescaline, Peyote, Salvia Divinorum)YouthGrade School, Post-Secondary School, Raves, Secondary School